Skip to content
Douglas Pharmaceuticals
Just another WordPress site
Category:
Research
Douglas Pharmaceuticals secures US licensing deal to treat high grade cervical dysplasia
Formation of Clinical Advisory Board for Lead Program R-107
Trial data suggests major breakthrough in Treatment Resistant Depression
Douglas Pharmaceuticals tackles treatment-resistant depression
